TAS2R31 (t2r31_human)

FAMILY

Class T (Taste 2) Sensory receptors Taste 2 receptors TAS2R31

GENE

TAS2R31 (TAS2R44)

ORGANISM

Human (Homo sapiens)

ALT. NAMES

Taste receptor type 2 member 31, T2R31, Taste receptor type 2 member 44, T2R44, Taste receptor type 2 member 53, T2R53

SOURCE

SWISSPROT

SEQUENCE

N-term TM1  
M
T
T
F
I
P
I
I
F
S
10
                   
S
V
V
V
V
L
F
V
I
G
20
                   
N
F
A
N
G
F
I
A
L
V
30
                   
N
S
I
E
R
V
K
R
Q
K
40
ICL1 TM2      
I
S
F
A
D
Q
I
L
T
A
50
                   
L
A
V
S
R
V
G
L
L
W
60
                   
V
L
L
L
N
W
Y
S
T
V
70
    ECL1 TM3  
F
N
P
A
F
Y
S
V
E
V
80
                   
R
T
T
A
Y
N
V
W
A
V
90
                   
T
G
H
F
S
N
W
L
A
T
100
                   
S
L
S
I
F
Y
L
L
K
I
110
  ICL2          
A
N
F
S
N
L
I
F
L
H
120
      TM4        
L
K
R
R
V
K
S
V
I
L
130
                   
V
M
L
L
G
P
L
L
F
L
140
                   
A
C
Q
L
F
V
I
N
M
K
150
    ECL2        
E
I
V
R
T
K
E
Y
E
G
160
                   
N
L
T
W
K
I
K
L
R
S
170
          TM5    
A
V
Y
L
S
D
A
T
V
T
180
                   
T
L
G
N
L
V
P
F
T
L
190
                   
T
L
L
C
F
L
L
L
I
C
200
                   
S
L
C
K
H
L
K
K
M
Q
210
      ICL3 TM6
L
H
G
K
G
S
Q
D
P
S
220
                   
T
K
V
H
I
K
A
L
Q
T
230
                   
V
I
F
F
L
L
L
C
A
V
240
                   
Y
F
L
S
I
M
I
S
V
W
250
        ECL3 TM7
S
F
G
S
L
E
N
K
P
V
260
                 
F
M
F
C
K
A
I
R
F
S
270
                   
Y
P
S
I
H
P
F
I
L
I
280
    H8            
W
G
N
K
K
L
K
Q
T
F
290
                   
L
S
V
L
R
Q
V
R
Y
W
300
  C-term    
V
K
G
E
K
P
S
S
P

LINKS

BitterDB

ChEMBL

Guide To Pharmacology

UniProt

DIAGRAMS

ICL1 K I ICL1ECL1 P A F Y ECL1ICL2 N F S N L I F L H L K R ICL2ECL2 V R T K E Y E G N L T W K I K L R S A V Y L S ECL2ICL3 K G S Q ICL3ECL3 L E N ECL3N-term M N-termC-term K G E K P S S P C-term T T F I P I I F S S V V V V L F V I G N F A N G F I A L V N S I E R V K R Q S F A D Q I L T A L A V S R V G L L W V L L L N W Y S T V F N S V E V R T T A Y N V W A V T G H F S N W L A T S L S I F Y L L K I A R V K S V I L V M L L G P L L F L A C Q L F V I N M K E I D A T V T T L G N L V P F T L T L L C F L L L I C S L C K H L K K M Q L H G D P S T K V H I K A L Q T V I F F L L L C A V Y F L S I M I S V W S F G S K P V F M F C K A I R F S Y P S I H P F I L I W G N K K F L S V R Y L K Q T V L R Q W V
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

G N A F N G I V F L V V V V S S F I I P 1 T A L A V S R V G L L W V L L L N W Y S 2 S T A L W N S F H G T V A W V N Y A T T 3 I L V M L L G P L L F L A C Q L F V I N 4 F C L L T L T F P V L N G L T T V T A D 5 V I F F L L L C A V Y F L S I M I S V W 6 F P H I S P Y S F R I A K C F M F V P 7
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

MUTATIONS

0 mutation data points available.

ENDOGENOUS LIGANDS

No endogenous ligands available

STRUCTURE MODELS

t2r31_human active,

t2r31_human inactive

STRUCTURES

No structures available